You have searched for "vaccine trial"
Showing 1-10 of 188
(Reuters) -The United States has put Johnson and Johnson in charge of a plant that ruined 15 million doses of its COVID-19 vaccine and has stopped British drugmaker AstraZeneca Plc from using the facility, a senior health official said on Saturday.
Papua New Guinea's health minister calls disinformation spread on Facebook the "biggest challenge" in the nation's fight against the Covid-19 pandemic.
Misinformation threatens to scuttle Papua New Guinea's already faltering efforts to bring a severe Covid-19 outbreak under control, with a survey showing one-in-four health workers are reluctant to get vaccinated.
BANGKOK (The Nation/ANN): The Government Pharmaceutical Organisation (GPO) kicked off the first phase of human trials for its Covid-19 vaccine on Monday (March 22) by delivering shots to 18 volunteers.
AMSTERDAM, March 18 (Reuters) - The EU's drug watchdog said on Thursday it is still convinced the benefits of AstraZeneca's COVID-19 vaccine outweigh the risks following an investigation into reports of blood disorders that prompted more than a dozen nations to suspend its use.
ZURICH (Reuters) - Vaccines from AstraZeneca, Russia's Gamaleya Institute and Johnson & Johnson fight the coronavirus with another virus, leaving scientists concerned the shots may lose potency if annual inoculations become necessary to fight new variants. So-called viral vector shots - also used by several Chinese COVID-19 vaccine developers - use harmless modified viruses as vehicles, or vectors, to carry genetic information that helps the body build immunity against future infections. However, there is a risk that the body also develops immunity to the vector itself, recognising it as an intruder and trying to destroy it.
PETALING JAYA: Access to a variety of vaccines makes fighting the Covid-19 pandemic that much easier and health experts are hoping that more people in the country can get their immunisation sooner.
KUALA LUMPUR: The Health Ministry (MOH) is looking for more volunteers to take part in Phase 3 of the Covid-19 vaccine clinical trial.
LONDON (Reuters) - It is not yet clear whether the world needs a new set of vaccines to fight different variants of the novel coronavirus but scientists are working on new ones so there is no reason for alarm, the head of the Oxford Vaccine Group said on Tuesday.